Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism

Conditions:   Pulmonary Embolism With Acute Cor Pulmonale;   Pulmonary Embolism;   Pulmonary Embolism With Pulmonary Infarction;   Pulmonary Embolism Subacute Massive;   Right Ventricular Dysfunction;   Right Ventricular Failure Interventions:   Drug: Alteplase;   Drug: Unfractionated heparin;   Drug: Placebo;   Drug: Apixaban Sponsors:   Victor Tapson, MD;   Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials